These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22512538)

  • 1. The heat shock response in FAP: the role of the extracellular chaperone clusterin.
    Magalhães J; Saraiva MJ
    Amyloid; 2012 Jun; 19 Suppl 1():3-4. PubMed ID: 22512538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
    Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the heat shock response in familial amyloidotic polyneuropathy.
    Santos SD; Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2008 May; 67(5):449-55. PubMed ID: 18431252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
    Hou X; Aguilar MI; Small DH
    FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
    Ando Y
    Amyloid; 2003 Aug; 10 Suppl 1():55-66. PubMed ID: 14640043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
    Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
    J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
    Saraiva MJ; Costa PP; Goodman DS
    J Lab Clin Med; 1983 Oct; 102(4):590-603. PubMed ID: 6311926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of serum transthyretin by electrospray ionisation-ion mobility mass spectrometry: Application to familial amyloidotic polyneuropathy type I (FAP-I).
    Pont L; Benavente F; Vilaseca M; Giménez E; Sanz-Nebot V
    Talanta; 2015 Nov; 144():1216-24. PubMed ID: 26452950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Only amyloidogenic intermediates of transthyretin induce apoptosis.
    Andersson K; Olofsson A; Nielsen EH; Svehag SE; Lundgren E
    Biochem Biophys Res Commun; 2002 Jun; 294(2):309-14. PubMed ID: 12051711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form.
    Lindhagen-Persson M; Vestling M; Reixach N; Olofsson A
    Amyloid; 2008 Dec; 15(4):240-5. PubMed ID: 19065295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
    Susuki S; Ando Y; Sato T; Nishiyama M; Miyata M; Suico MA; Shuto T; Kai H
    Amyloid; 2008 Jun; 15(2):108-16. PubMed ID: 18484337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthyretin is not expressed by dorsal root ganglia cells.
    Sousa MM; Saraiva MJ
    Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Yamashita T; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():8-10. PubMed ID: 22524183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.
    Magalhães J; Santos SD; Saraiva MJ
    Int J Exp Pathol; 2010 Dec; 91(6):515-21. PubMed ID: 20804537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
    Dardiotis E; Koutsou P; Zamba-Papanicolaou E; Vonta I; Hadjivassiliou M; Hadjigeorgiou G; Cariolou M; Christodoulou K; Kyriakides T
    J Neurol Sci; 2009 Sep; 284(1-2):158-62. PubMed ID: 19493541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
    Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
    Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.